Signalment, clinical features, echocardiographic findings, and outcome : 109 cases (1992–2013)
To determine the signalment, clinical features, echocardiographic findings, and outcome of dogs and cats with ventricular septal defects (VSDs).
Authors : Eric Bomassi, DVM ; Charlotte Misbach, DVM, PhD; Renaud Tissier, DVM, PhD; Vassiliki Gouni, DVM, PhD; Emilie Trehiou-Sechi, DVM; Amandine M. Petit, DVM; Aude Desmyter, DVM; Cécile Damoiseaux, DVM; Jean-Louis Pouchelon, DVM, PhD; Valérie Chetboul, DVM, PhD
From the Centre Hospitalier Vétérinaire des cordeliers, 29 Avenue du maréchal joffre, 77100 Meaux, France (Bomassi); Unité de cardiologie d’Alfort (Misbach, Gouni, Trehiou-Sechi, Petit, Desmyter, Damoiseaux, Pouchelon, Chetboul) and Unité de pharmacie-toxicologie (Tissier), Université Paris-Est, Ecole Nationale Vétérinaire d’Alfort, Centre Hospitalier Universitaire Vétérinaire d’Alfort, 94704 Maisons-Alfort cedex, France; and INSERM U955, Equipe 03, 51 Avenue du maréchal de lattre de tassigny, 94010 Créteil cedex, France (Tissier, Pouchelon, Chetboul).
This study was not supported by any grant or other funding.
Address correspondence to Dr. Chetboul (firstname.lastname@example.org).
Scientific Reports : JAVMA, Vol 247, No. 2, July 15, 2015. P166-175
Retrospective case series.
56 dogs and 53 cats with VSDs.
Medical records of dogs and cats with VSDs diagnosed by means of conventional and Doppler echocardiography were reviewed. Signalment, clinical status, echocardiographic findings, and outcome data were recorded. Variables of interest were analyzed for the study population and subgroups according to species and clinical status.
VSDs were isolated (ie, solitary defects) in 53 of 109 (48.6%) patients. Most (82/109 [75.2%]) VSDs were membranous or perimembranous. Terriers and French Bulldogs were commonly represented canine breeds. Most isolated VSDs were subclinical (43/53 [81%]) and had a pulmonary-to-systemic flow ratio < 1.5 (24/32 [75%]). The VSD diameter and VSD-to-aortic diameter ratio were significantly correlated with pulmonary-tosystemic flow ratio in dogs (r = 0.529 and r = 0.689, respectively) and in cats (r = 0.713 and r = 0.829, respectively). One dog underwent open surgical repair for an isolated VSD and was excluded from survival analysis. Of the remaining animals with isolated VSDs for which data were available (37/52 [71%]), no subclinically affected animals developed signs after initial diagnosis, and median age at death from all causes was 12 years.
Most dogs and cats with isolated VSDs had a long survival time; few had clinical signs at diagnosis, and none with follow-up developed clinical signs after diagnosis. (J Am Vet Med Assoc 2015;247:166–175)
ASD Atrial septal defect
CHD Congenital heart disease
IVS Interventricular septum
Qp:Qs Pulmonary-to-systemic flow ratio
VSD Ventricular septal defect
VSD:Ao VSD-to-aortic diameter ratio
AVSD consists of an opening in the IVS resulting from incomplete development or misalignment of the IVS during the embryonic period.1,2 Several VSD types have been defined according to the location of the defect within the IVS.
Supracristal VSDs (also known as conoseptal, subarterial, or infundibular VSDs) are found below the right and noncoronary aortic valve cusps in conal or outlet regions of the IVS. Conversely, membranous VSDs are located within the membranous portion of the IVS just below the aortic valve cusps. If the defect extends to the dorsal part of the muscular portion of the IVS, VSDs are described as perimembranous, paramembranous, or conoventricular (the 2 latter terms being more appropriate).3–5 Muscular VSDs are entirely enclosed in the muscular IVS and may involve the inlet, outlet, or trabecular parts of the IVS.3 Lastly, a fourth form of VSD is also described: atrioventricular canal type VSDs (involving the inlet of the right IVS portion immediately beneath the atrioventricular valve apparatus). Additionally, VSDs may be isolated, multiple, or concomitant with other CHDs. Isolated VSDs, regardless of the type, usually result in a left-to-right shunting across the defect, and both the magnitude of the shunting flow and its cardiac consequences are mainly determined by the size of the defect and also pulmonary vascular resistances.
Ventricular septal defects have been extensively studied in people and they are considered the most common human CHD, representing 324 of 1,000 (32.4%) to 1,492 of 2,867 (52.0%) of all CHDs in several studies.6–11 Conversely, VSDs seem to be less common in dogs, accounting for 17 of 276 (6.2%) to 20 of 162 (12.3%) of CHDs in this species,12–19 and the reported proportion of VSDs in cats is variable, ranging from 13 of 107 (12.1%) to 27 of 48 (56%) of CHDs according to different sources.12,13,16,20,21
Ventricular septal defects in dogs and cats have mainly been studied in the context of retrospective reviews of CHDs.12–14,17–22 Data from large populations of animals affected by VSDs are therefore lacking, and to the best of the authors’ knowledge, the comparative survival time and prognostic factors predictive of survival in dogs and cats with VSDs remain unknown.
The aims of the study reported here were to investigate the signalment and clinical and echocardiographic features of dogs and cats with VSDs and to assess the long-term clinical outcome of affected animals, including survival rates for animals with isolated VSDs.
Hard copy and electronic medical records for client-owned dogs and cats that underwent conventional (ie, M-mode and 2-D) echocardiographic and standard Doppler echocardiographic examination, leading to the diagnosis of VSD, at the Cardiology Unit of Alfort, National Veterinary School of Alfort, Maisons-Alfort, France, and at the Centre Hospitalier Vétérinaire des Cordeliers, Meaux, France, between October 1, 1992, and October 31, 2013 were evaluated. Dogs and cats with isolated or nonisolated VSDs confirmed by color flow Doppler echocardiography were included in the study. Animals with equivocal Doppler echocardiography results or for which color flow Doppler mode was not used to confirm a VSD were excluded.
Species, breed, age, sex, and body weight were obtained from the medical records. Clinical status at the time of diagnosis, echocardiographic findings (including presence and type of concomitant CHD, if applicable) and measurements, and any outcome data included in the record were also recorded.
Standard 2-D, M-mode, and Doppler examinations were performed in awake standing animals with continuous ECG monitoring by trained observers using ultrasonography unitsa–e as previously described.23,24 Transverse diameters of the aorta and the left atrium were measured in late diastole with a 2-D method by use of the right parasternal short-axis view at the level of the aortic valve, and the left atrial-to-aortic diameter ratio was calculated as described elsewhere.25 Presence of VSD was assessed on right parasternal long-axis 4- or 5-chamber views and by examination of the IVS on right or left long-axis, short-axis, or oblique views.26,27 Transverse views of the heart base, just proximal to the pulmonic valve within the right ventricular outflow tract, were also examined.26,27 Color flow Doppler mode was used to visualize and confirm the presence of VSD. Both color flow and continuous-wave Doppler modes were used to assess the shunt direction (left-to-right, right-to-left, or bidirectional), as previously described.27–29 Continuous-wave Doppler mode was also used to measure the maximal velocity through the defect. The maximal size of the defect (ie, VSD diameter), which may vary according to the phases of the cardiac cycle, was measured from Doppler color flow map echocardiograms at the level of the defect through the IVS (Figure 1).27 Color flow Doppler images were analyzed frame by frame to compute the maximum area of the VSD jet signal, and the largest color flow VSD diameter was then measured.
The VSD:Ao was then calculated. Aortic regurgitation, when present, was classified as mild if the jet width was < 25% of the dimension of the left ventricular outflow tract (jet width ratio) on the right parasternal 5-chamber view and as moderate or severe if the jet width ratio was between 25% and 65% or > 65%, respectively, in color flow Doppler mode.30 Aortic cusp prolapse assessed with the 2-D mode was noted as present or absent. The Qp:Qs, which represents the magnitude of left-to-right shunting, was assessed by combining 2-D echocardiography and pulsed-wave Doppler mode data as previously described (ie, pulmonary and systemic flow rates were obtained by multiplying crosssectional areas of the pulmonary trunk and aortic root, with the velocity-time integrals of pulmonary and aortic flows, respectively).9,26,31 Ventricular septal defects were considered as small (restrictive), moderate (moderately restrictive), or large (nonrestrictive) if Qp:Qs was < 1.5, between 1.5 and 2.5, and > 2.5, respectively.32,33 Concomitant CHDs were also recorded.
Ventricular septal defects were classified on the basis of echocardiographic findings as isolated (ie, solitary lesions) or nonisolated (with ≥ 1 other CHD present). They were also divided into 4 types according to their localization and anatomic features.3,5,7,33–37 Type 1 VSDs were supracristal, type 2 VSDs were membranous or perimembranous, and type 3 and 4 VSDs were atrioventricular canal type and muscular VSDs, respectively.
At the time of diagnosis, animals were classified as either clinically or subclinically affected (ie, with or without clinical signs attributed to VSD, such as exercise intolerance, signs of congestive heart failure, syncope, and cyanosis, respectively). Exercise intolerance was defined as a decreased capacity of usual daily exercise as noted by the owners.
Follow-up was based on a review of the patient’s records and was performed for animals with isolated VSDs only. Owners of animals for which the outcome could not be found in the database were contacted by telephone, mail, or email to determine the current status of their animals: alive (clinically or subclinically affected) or dead (date and cause of death, if known). Animals that were subclinically affected at the time of diagnosis were considered as stable (or nondecompensated) if they remained subclinically affected at the time of last follow-up or as decompensated if they had developed ≥ 1 of the clinical signs attributed to VSD. Animals for which the outcome could not be obtained were considered lost to follow-up and were consequently censored at the time of their last examination.
Statistical analyses were performed by computer software.f Data were expressed as proportion, percentage, or median and range and compared among groups by the log rank test. Survival curves were determined by the Kaplan-Meier method. Variables of interest were compared between groups (species [dog vs cat] and clinical sign [present vs absent] subgroups) by means of a Mann-Whitney test. Correlations between VSD diameter or VSD:Ao and echocardiographic variables of interest were assessed by means of the Spearman rank test. Values of P ≤ 0.05 were considered significant.
Figure 1—Representative color flow Doppler mode echocardiograms used to visualize the VSD and measure the maximal VSD size (ie, VSD diameter) in a cat (A) and a dog (B).
A—Right parasternal 5-chamber view showing a left-to-right shunt through a moderate perimembranous VSD, represented by an aliased turbulent flow accelerating in the left ventricular outflow tract just below the aortic valve into the right ventricle across the defect. Measurement of the VSD diameter is shown by the double-headed arrow.
B—Visualization of a left-to-right shunt through a small supracristal VSD and measurement of the maximal diameter of the defect (double-headed arrow) on the right parasternal shortaxis view at the level of the aortic valve. Scales on the left side of each image represent distance to the transducer (in cm).
Ao = Aorta. LA = Left atrium. LV = Left ventricle. PT = Pulmonary trunk. RV = Right ventricle. RVOT = Right ventricular outflow tract.
The study population consisted of 109 animals (56 dogs and 53 cats) with a diagnosis of VSD. Of these, 88 were evaluated at the Cardiology Unit of Alfort and 21 at the Centre Hospitalier Vétérinaire des Cordeliers. The 56 dogs represented 30 breeds, including French Bulldog (8 [14%]); Fox Terrier (4 [7%]); Jack Russell Terrier, English Bulldog, Cocker Spaniel, and mixed (3 [5%] each); and Poodle, Cavalier King Charles Spaniel, German Shepherd Dog, Maltese, Collie, West Highland White Terrier, Yorkshire Terrier, and Border Terrier (2 [4%] each). Sixteen other breeds, including 5 of terrier type, comprised < 2% of the canine population.
There were 34 male and 22 female dogs; median age at the time of VSD diagnosis was 9 months (range, 2.2 months to 11.8 years), and median weight was 8 kg (17.6 lb; range, 1 to 60 kg [2.2 to 132 lb]). The 53 cats comprised 9 breeds, including domestic shorthair (35 [66%]), Maine Coon (6 [11%]), Norwegian Forest Cat and Sphynx (3 [6%] each), and Persian (2 [4%]). Less than 2% of the cats were of other breeds. There were 27 male and 26 female cats. Median age was 1 year (range, 1.5 months to 12.7 years), and median weight was 3.8 kg (8.4 lb; range, 0.9 to 7.7 kg [2.0 to 17.0 lb]).
An isolated VSD was diagnosed in 53 of 109 (48.6%) animals, including 26 of 56 (46%) dogs and 27 of 53 (51%) cats. Of the remaining 56 animals, tetralogy of Fallot was diagnosed in 20 (36%; 10/30 [33%] dogs and 10/26 [38%] cats). Among patients with tetralogy of Fallot were 1 dog with 4 concomitant CHDs (aortic stenosis, ASD, persistent left cranial vena cava, and an abnormal right coronary artery) and 2 cats with 2 concomitant CHDs each (1 with mitral valve dysplasia and ASD, and 1 with mitral and tricuspid valve dysplasia). Other cases of VSD with pulmonic stenosis included 5 of 56 (9%) dogs, 1 of which also had mitral valve dysplasia. In total, VSD with pulmonic stenosis with and without other CHDs comprised 25 of 56 (45%) VSD associations.
In the remaining 15 dogs and 16 cats, VSDs were found in various combinations with ≥ 1 of the following conditions: mitral valve dysplasia (7 dogs and 9 cats), ASD (4 dogs and 3 cats), aortic stenosis (4 dogs and 3 cats), tricuspid valve dysplasia (2 dogs and 4 cats), persistent left cranial vena cava (2 dogs and 2 cats), persistent truncus arteriosus (1 dog and 1 cat), quadricuspid aorta (2 dogs), and mitral valve stenosis (1 cat).
Two-dimensional and color flow Doppler mode echocardiography revealed that the most common VSDs in the study population were type 2 (membranous and perimembranous). These were identified in 82 of 109 (75.2%) animals, including 40 of 56 dogs (15 and 25 with isolated and nonisolated VSDs, respectively) and 42 of 53 cats (22 and 20 with isolated and nonisolated VSDs, respectively). Type 1 (supracristal) VSDs were the next most common, identified in 22 of 109 (20.2%) animals (15 dogs [10 with isolated and 5 with nonisolated VSDs] and 7 cats [4 with isolated and 3 with nonisolated VSDs]). Only 3 animals (1 dog and 2 cats) had type 3 (atrioventricular canal type) VSDs, and only 2 (both cats) had type 4 (muscular) VSDs.
At the time of diagnosis, a systolic heart murmur heard best at the right sternal border (median grade 4/6; range, 3/6 to 5/6) was detected in all animals with isolated VSDs (n = 53 [26 dogs and 27 cats]). Forty-three of 53 (81%) patients were subclinically affected at the time of diagnosis. The remaining 10 animals (19%; 4 dogs and 6 cats) had ≥ 1 clinical sign. These included respiratory signs, such as dyspnea (n = 8 [2 dogs and 6 cats]); cough (3 [2 dogs and 1 cat]); and thoracoabdominal asynchrony (also called paradoxical breathing38), characterized by increased inspiratory effort resulting in sunken flanks when the thorax expands and bulging flanks when the thorax is depressed (2 cats, both with pleural effusion). Cyanosis was detected in 1 dog, and exercise intolerance was reported for 2 dogs. Congestive heart failure (evidenced by pulmonary edema or pleural effusion) was detected in 4 of the 10 clinically affected animals (3 cats and 1 dog).
Treatment status at the time of diagnosis was known for all 53 animals with isolated VSDs: 44 (83% [21 dogs and 23 cats]) were untreated, and 9 (17% [5 dogs and 4 cats]) were receiving ≥ 1 of the following drugs: angiotensin-converting enzyme inhibitors (eg, benazepril, enalapril, imidapril, or ramipril; 6/53 [11%]; 4 dogs and 2 cats), furosemide (2/53 [4%]; 1 dog and 1 cat), spironolactone (4/53 [8%]; 3 dogs and 1 cat), altizide (2/53 [4%]; both dogs), and diltiazem (1/53 [2%]; a cat).
Some quantitative data were not available for all animals. Data regarding VSD diameter, assessed by color flow Doppler mode, were available for 46 of 53 (87%) animals (21 dogs and 25 cats) with a diagnosis of isolated VSD. Median VSD diameter was 3.9 mm (range, 1.4 to 12 mm) for dogs and 3.5 mm (range, 1 to 12 mm) for cats. The VSD:Ao was calculated for 42 of the 53 animals (79%; 20 dogs and 22 cats); median values were 0.23 (range, 0.08 to 0.57) and 0.32 (range, 0.16 to 1.30) for dogs and cats, respectively.
The direction of the shunt, assessed by means of combined color flow and continuous-wave Doppler modes, was left-to-right for 51 of 53 (96%) animals with isolated VSD, and right-to-left (consistent with an Eisenmenger complex) for the remaining 2 (4%). The 2 patients with right-to-left shunt were a dog with a VSD diameter of 7.4 mm and VSD:Ao of 0.45 and a kitten with a VSD diameter of 7.8 mm and VSD:Ao of 1.30. Maximal flow velocity through the defect, calculated in the continuous-wave Doppler mode for left-to-right shunts, was available for 37 animals. Median maximum flow velocity was 5.13 m/s (range, 0.57 to 6.75 m/s) for all animals (n = 37), 5.13 m/s (range, 3 to 6.75 m/s) for dogs (19), and 4.86 m/s (range, 0.57 to 6.72 m/s) for cats (18). Most (28/37 [76%]) patients had maximum flow velocity between 4.8 and 6.75 m/s.
Pulmonary-to-systemic flow ratio was calculated for 32 of 53 (60%) animals with isolated VSDs, all with left-to-right shunts. The median Qp:Qs was 1.2 (range, 0.83 to 2.70) for 17 dogs and 1.35 (range, 0.76 to 2.48) for 15 cats. The Qp:Qs was < 1.5 for 24 of 32 (75%) animals (12 dogs and 12 cats), 1.5 to 2.5 for 6 (19%) animals (3 dogs and 3 cats), and > 2.5 for 2 (6%) animals (both dogs).
Aortic regurgitation was present in 19 of 53 (36%) animals (15 dogs and 4 cats) with isolated VSDs and was considered mild for 12 animals (9 dogs and 3 cats), moderate in 3 (2 dogs and 1 cat), and severe in 4 (all dogs). Nine of the 19 animals with aortic regurgitation had type 1 VSDs, and the other 10 had type 2 VSDs. Aortic cusp prolapse was identified only in dogs with type 1 VSD (n = 3) and was associated with moderate and severe aortic regurgitation in 1 and 2 dogs, respectively.
The Qp:Qs was significantly correlated with VSD diameter whether evaluated in the population of study animals for which data were available (n = 32; r = 0.579; P < 0.001), in dogs (17; r = 0.529; P = 0.028), or in cats (15; r = 0.713; P = 0.002). The Qp:Qs was also significantly correlated with VSD:Ao in the study population for which data were available (n = 32; r = 0.702; P < 0.001), in dogs (17; r = 0.689; P = 0.002), and in cats (15; r = 0.829; P < 0.001). The strongest correlations were found for the VSD:Ao (Figure 2).
Data regarding both VSD diameter and presence or absence of clinical signs were available for 46 of 53 animals with isolated VSDs (10 clinically affected and 36 with subclinical disease). Dogs with clinical signs attributed to VSD (n = 4) had a significantly (P = 0.039) greater VSD diameter (median, 5.8 mm; range, 4.1 to 12.0 mm) than did subclinically affected dogs (17; median, 3.3 mm; range, 1.4 to 8.4 mm). However, VSD diameter did not differ significantly (P = 0.258) between cats with (n = 6; median, 4.3 mm; range, 1.6 to 12.0 mm) and without (19; median, 2.7 mm; range, 1.0 to 7.5 mm) clinical signs attributed to VSD.
Data for VSD:Ao, together with the presence or absence of clinical signs, were available for 42 of the 53 animals (8 and 34 clinically and subclinically affected, respectively). Results were similar to those found for VSD diameter; the VSD:Ao was significantly (P = 0.02) greater in dogs with (n = 4; median, 0.36; range, 0.23 to 0.57) than in dogs without (16; median, 0.22; range, 0.08 to 0.45) clinical signs attributed to VSD. In cats, the VSD:Ao did not differ significantly (P = 0.726) between clinically (n = 4; median, 0.3; range, 0.19 to 1.3) and subclinically affected (18; median, 0.32; range, 0.16 to 0.96) animals.
Data regarding Qp:Qs and the presence or absence of clinical signs were available for 32 of the 53 animals (5 clinically affected and 27 subclinically affected). The Qp:Qs was significantly (P = 0.02) greater in clinically affected (median, 2.17; range, 1.27 to 2.7) than subclinically affected (median, 1.2; range, 0.76 to 2.48) animals. The Qp:Qs was also significantly (P = 0.004) greater in dogs with (n = 4; median, 2.35; range, 1.7 to 2.7) than in dogs without (13; median, 1.11; range, 0.83 to 1.61) clinical signs attributed to VSD. Differences between clinically and subclinically affected cats were not calculated because only 1 cat (Qp:Qs, 1.27) was clinically affected (vs 14 subclinically affected cats; median, 1.37; range, 0.76 to 2.48).
Figure 2—Correlations of Qp:Qs with VSD diameter and VSD:Ao in 32 of 53 study animals with isolated VSDs for which data were available (A and B) and in subpopulations of dogs (C and D; 17/32) and cats (E and F; 15/32).
One dog with an isolated large VSD (12 mm in diameter; Qp:Qs, 2.65) underwent a successful surgical closure of the defect (by means of an open beating heart surgical technique with cardiopulmonary bypass) and was therefore excluded from subsequent statistical analyses. The dog was reportedly doing well 8 years after VSD closure, with no recurrence of the previous clinical signs (exercise intolerance) attributed to VSD before surgery.
Follow-up data were available for 37 of the remaining 52 animals with an isolated VSD (16 dogs and 21 cats). Twenty-nine of the 37 animals were subclinically affected and 8 were clinically affected at the time of diagnosis. None of the 29 subclinically affected animals with follow-up data available developed clinical signs attributable to VSD after the initial examination.
Owing to the high proportion of dogs with isolated VSD that remained subclinically affected at the end of the study period (13/16), median age at development of clinical signs could not be calculated in this species, whereas median age for this finding in cats was 12 years (Figure 3).
Death from any cause was reported for 13 of 37 animals (6 dogs and 7 cats) at a median age of 12 years. The median age was 12 years for dogs and 12.1 years for cats, with no significant (P = 0.979) difference between the 2 groups.
Cardiac death related to left-sided congestive heart failure was only reported for 3 animals (2 cats at 1.4 and 12.1 years of age and 1 dog at 1.5 years of age); these were among the 8 animals clinically affected at the time of diagnosis for which follow-up data were available. Of these 3, cardiac-related death of only 1 cat was considered strictly related to VSD, because the dog and the remaining cat had developed severe acquired heart disease at adult age (dilated cardiomyopathy and degenerative mitral valve disease, respectively). The cat with VSD-related death had a large type 3 VSD (12 mm in diameter; Qp:Qs data unavailable) with a left-to-right shunt at the time of diagnosis.
Of the remaining 5 animals (2 dogs and 3 cats) that were clinically affected at the time of VSD diagnosis and had follow-up data available, the evaluation and diagnosis of VSD were considered recent (occurring 0.9 and 2.4 years before the end of the study) for 4. Diagnosis for the remaining animal, a dog, was made approximately 4 years before the end of the study. Medical treatment was ongoing for 3 of these 5 animals (2 dogs and 1 cat with left-to-right shunts). The 2 dogs were receiving benazepril as well as spironolactone and altizide, and the cat was receiving benazepril and furosemide. The 2 untreated animals included a cat that was 10.8 years old at the end of the study (with a diagnosis of type 1 VSD at 9.6 years of age) and a cat that was 1.7 years old at the end of the study (with a diagnosis of a type 2 VSD [7.8 mm in diameter; Qp:Qs data unavailable] at 9.2 months of age). The older cat had a left-to-right shunt and VSD:Ao of 0.38, and the younger cat had a right-to-left shunt with a VSD:Ao of 1.3.
Median time to cardiac-related death in the 2 species subgroups could not be calculated, because of the high proportion of animals with isolated VSDs that did not have death attributable to cardiac disease (Figure 4). Age at development of clinical signs attributed to VSD (P = 0.989) and age at death from all causes (P = 0.366) or from cardiac causes (P = 0.748) were not associated with the presence or absence of aortic regurgitation.
Although some reports describe VSD as the fourth to sixth most common canine CHD12–14,17,18 and the primary cause of heart failure in cats with CHD,21 few studies32,36,39–49 have specifically focused on the natural history of VSD in small companion animals, and most of these have been clinical reports or case series describing small numbers of animals. The present study provides original data regarding the signalment, clinical features, and standard and Doppler echocardiographic findings for 109 animals with isolated or nonisolated VSDs.
In agreement with previous reports,12–14,17–19,21 this study found that canine and feline VSDs were frequently diagnosed in conjunction with other CHDs (ie, approx half of the cases in both species), highlighting the need to systematically perform complete echocardiographic examinations in small animals. The most common concomitant CHD in dogs, as also described in another large European study19 that included 976 cases of CHD in dogs, was pulmonic stenosis, either identified as an isolated defect or in the context of tetralogy of Fallot, which is a complex CHD including VSD, pulmonic stenosis, right ventricular hypertrophy, and malpositioned (overriding) aorta. This VSD-pulmonic stenosis combination represented 25 of 56 (45%) VSD associations in animals of our study. Tetralogy of Fallot was also the most common concomitant CHD in cats, accounting for 10 of 26 (38%) VSD associations in this species. However, no VSD was diagnosed concomitantly with pulmonic stenosis as the only other cardiac abnormality in cats.
In the present study, the most represented canine breeds were of the terrier type, accounting for more than one-third of the dogs with VSD. Similarly, some authors have reported a predisposition to VSD among Lakeland Terriers and West Highland White Terriers. 12,13,50,51 However, in contrast to those studies,12,13,50,51 no Keeshonds or English Springer Spaniels were identified in the present investigation, whereas French Bulldog was the single most commonly affected breed (8/56 [14%] dogs). This apparent discrepancy among studies can likely be explained by the fact that French Bulldog is a popular breed in Europe, particularly in France, where the study was performed. Investigators in Italy found a similar significant predisposition of French Bulldogs to VSD, with an OR of 7.2 in comparison to a reference population.19 In the study by Oliviera et al,19 Doberman Pinschers had the highest odds of VSD, followed by French Bulldogs and German Shepherd Dogs, whereas only 2 German Shepherd Dogs and 1 Doberman Pinscher were included in our study. Similar to the condition in humans,7 VSDs in these canine breeds are highly suspected to have a genetic basis, as described in Keeshonds having a polygenic inheritance.51,52 This should be further investigated by pedigree and genetic analyses. In the present study, the domestic shorthair breed was predominant among cats, representing 35 of 53 (66%) with VSD, followed by Maine Coon, Norwegian Forest Cat, and Sphynx breeds.
As recommended for human patients, 2-D echocardiography combined with color flow Doppler mode was chosen to confirm VSDs in our study population. These combined ultrasonographic techniques are considered the most sensitive tools for noninvasive diagnosis of human VSDs and for determining the size and location of the defects as well as identifying concomitant valvular regurgitation.7,9,27,34,53 These imaging data provide crucial information for cardiac surgeons before performing VSD repair, both to choose the optimal closure technique and to assess potential VSD-associated risk factors.33–35,53–56 Although 3-D echocardiography has been shown to provide an accurate visualization of defects in humans that may be difficult to assess in the 2-D mode,7,11,57 the 3-D technique was not used in the present study. Nevertheless, as previously described for humans4–6,54–56 and for dogs,3,58 our study found that most VSDs, whether isolated or nonisolated, were type 2 in dogs (40/56 [71%]) and cats (42/53 [79%]). The second most common VSD type in both species was type 1, representing 15 (27%) and 7 (13%) canine and feline VSDs, respectively. Type 3 and 4 VSDs, which are rarely described in the veterinary literature,3,58 were the least common VSD types in the present study, accounting for < 5% of the 109 diagnosed VSDs. Type 4 VSDs were not found in dogs and detected in only 2 of 53 (4%) affected cats.
In the present study, a median grade 4/6 systolic heart murmur heard best at the right sternal border was detected in all dogs and cats with isolated VSDs. Most (43/53 [81%]) of these animals were subclinically affected at the time of diagnosis, confirming other reports3,16,51 showing that isolated VSD in small animals is mainly an incidental finding, suspected by cardiac auscultation when a high-grade right systolic heart murmur is detected and confirmed by conventional and Doppler echocardiographic examination. Most (8/10) clinically affected animals with isolated VSD had respiratory signs, and many of these had multiple respiratory signs.
As expected, the dogs with clinical signs attributed to VSD on initial examination in the present study had a significantly greater VSD diameter and VSD:Ao than did those without clinical signs. Bonagura and Herring16 reported a good prognosis for dogs in which the VSD diameter was < 40% of the aortic root size. In contrast, no significant difference in VSD diameter or VSD:Ao was found between clinically and subclinically affected cats in the present study. Further studies, involving a larger number of clinically affected cats, are needed to clarify this point. Pulmonary-to-systemic flow ratio is an index reflecting the magnitude of left-to-right VSD shunting.31
In the present study, most animals with isolated VSD for which data were available (24/32 [75%]) had a Qp:Qs < 1.5, indicative of a restrictive VSD, associated with a good prognosis as reported in humans9,33,53 and confirmed here by the predominance of subclinically affected animals with isolated VSD both at the time of diagnosis and follow-up. Only 2 dogs had a large nonrestrictive VSD, characterized by Qp:Qs > 2.5. A high Qp:Qs is associated with poor prognosis and is an indication for closure surgery in humans9,33,53 and in dogs.44,59 In our study, 1 of the 2 dogs with Qp:Qs > 2.5 was successfully treated by surgery and had no recurrence of clinical signs 8 years after VSD closure. The other was treated with benazepril, spironolactone, and altizide and was still alive at the end of the study period (4 years after initial VSD diagnosis). As expected, significant correlations between Qp:Qs and other measures of VSD size (VSD diameter and VSD:Ao) were found in both cats and dogs with isolated VSDs. The strongest correlation was with the VSD:Ao, suggesting that, as in human patients with VSD,27 normalizing the defect size to aortic diameter is highly relevant for indirect assessment of VSD hemodynamic consequences in small companion animals, especially where small animals are characterized by breeds of different sizes and variable increases in body weight according to growth.
Defects located just below or close to the aortic valve can lead to a loss of structural support for the aortic valve apparatus and therefore may contribute to aortic regurgitation.3,36,50 The association between VSD and aortic regurgitation is well recognized in human patients,60 with reported prevalences of 36 of 854 (4.2%) to 78 of 139 (56.1%), depending on age.54,55,61 Although reported in dogs,41 the prevalence of aortic regurgitation associated with isolated VSD was still unknown in both dogs and cats. Our findings indicated that aortic regurgitation is commonly present with VSD in small animals, as it was detected in 19 of 53 (36%) animals with isolated VSD, mostly in dogs (15/19 affected animals), with most having mild aortic regurgitation without any aortic cusp prolapse.
Once aortic regurgitation has developed, it can predispose to bacterial endocarditis.42,62,63 However, bacterial endocarditis was not reported in any dogs or cats in the present study (at the time of diagnosis or during follow-up), although cases have occasionally been reported in dogs.42,43 Because of the risks of progression of left ventricular dilatation and myocardial failure, aortic regurgitation is recognized as one of the main risk factors for negative outcome in humans with VSDs, depending on its severity.33,60 In our study, the presence of aortic regurgitation in animals with isolated VSDs was not associated with age at development of clinical signs, death from all causes, or cardiac-related death. Nevertheless, on the basis of Doppler echocardiographic evaluation, aortic regurgitation was considered mild in 9 of 15 dogs and 3 of 4 cats with isolated VSDs. After exclusion of 1 dog that had undergone surgical VSD closure, Kaplan-Meier analysis revealed that the survival time of animals with isolated VSDs was high, given that median age at death from all causes was 12 years. Similarly, 39 of 52 (75%) animals were subclinically affected at 9.6 years of age and only 3 animals were known to have died of cardiac-related reasons. Only 1 of the 3 reported cardiac deaths could be related with any certainty to VSD alone, as an acquired heart disease was diagnosed concomitantly with VSD in the 2 remaining cases. Our results therefore suggest that most isolated VSDs in dogs and cats are associated with a good long-term prognosis and do not impact either the quality (as assessed by clinical signs) or duration of life.
The present study had several limitations, mainly related to its retrospective nature. Several echocardiographic (eg, VSD diameter and left atrial-to-aortic diameter ratio) and Doppler echocardiographic (eg, Qp:Qs) variables were missing for some animals, particularly those included > 15 years ago. Several animals were also lost to follow-up. Additionally, although useful to evaluate hemodynamic effects of VSD, the pulmonary arterial pressure was not assessed in the present study. In the most accurate recommended noninvasive method for evaluating systolic pulmonary artery pressure in patients with VSD, the modified Bernoulli equation is applied to both the maximal flow velocity across the defect and the systemic arterial blood pressure in systole.9,34 However, the latter was not assessed in our study population. Further, we used only 1 method to assess physical VSD diameter (ie, the widest VSD diameter from 2-D color flow map echocardiograms). Such measurement performed in a single plane may not accurately reflect the true VSD size, given that VSDs may have elliptical rather than round shapes. Several imaging methods have been described to accurately assess VSD sizes in human patients, including methods to calculate area from measurement of the widest diameters of the defect in 2 orthogonal planes in elliptical models.g
Lastly, our study only included alive animals that were evaluated at our 2 referral centers, thus excluding dogs and cats (likely with large VSDs) that died at young ages or without referral.
Our study, which focused on VSDs in > 100 dogs and cats, provided data outlining several important characteristics of this CHD. Further studies are needed to assess a potential genetic basis of VSD in some specific breeds such as French Bulldogs.
a. Vingmed System 5, General Electric Medical System, Waukesha, Wis.
b. Vivid 5, General Electric Medical System, Waukesha, Wis.
c. Vivid 7, General Electric Medical System, Waukesha, Wis.
d. Vivid E9, General Electric Medical System, Waukesha, Wis.
e. Megas and My Lab Twice, Esaote Biomedica, Firenze, Italy.
f. Systat, version 10.0, SPSS Inc, Chicago, Ill.
g. Webber SA, Ho SY, Anderson C, et al. Measuring the size of ventricular septal defect in hearts with double inlet left ventricle and tricuspid atresia: implications for noninvasive assessment of subaortic stenosis (abstr). Pediatric Res 1996;36:40.
1. Bishop SP. Embryologic development: the heart and great vessels. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;3–9.
2. Kittleson MD. Cardiac embryology and anatomy. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;1–4.
3. Kittleson MD. Ventricular septal defect. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;233–239.
4. Chen H, Xu Z, Wang S, et al. Eisenmenger ventricular septal defect: classification, morphology, and indications for surgery. Pediatr Cardiol 2011;32:17–23.
5. Van Praagh R, Geva T, Kreutzer J. Ventricular septal defect: how shall we describe, name and classify them? J Am Coll Cardiol 1989;14:1298–1299.
6. Kouchokos NT, Blackstone EH, Doty DB, et al. Ventricular septal defect. In: Park M, ed. Kirklin/Barratt-Boyes cardiac surgery. 3rd ed. Philadelphia: Churchill Livingstone Inc, 2003;850–888.
7. Minette MS, Sahn DJ. Ventricular septal defects. Circulation 2006;114:2190–2197.
8. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56109 births: incidence and natural history. Circulation 1971;43:323–332.
9. Aguilar NE, Eugenio Lopez J. Ventricular septal defects. Bol Asoc Med P R 2009;101:23–29.
10. Houyel L, Khoshnood B, Anderson RH, et al. Population-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code. Orphanet J Rare Dis 2011;6:64.
11. Penny DJ, Vick WG. Ventricular septal defect. Lancet 2011;377:1103–1112.
12. Buchanan JW. Congenital heart disease: prevalence of cardiovascular disorders. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;458–463.
13. Hunt GB, Church DB, Malik R, et al. A retrospective analysis of congenital cardiac abnormalities (1977–1989). Aust Vet Pract 1990;20:70–75.
14. Mulvihill JJ, Priester WA. Congenital heart disease in dogs: epidemiologic similarities to man. Teratology 1973;7:73–77.
15. Buchanan JW. Causes and prevalence of cardiovascular disorders. In: Kirk RW, Bonagura JD, eds. Current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;647.
16. Bonagura JD, Herring DS. Congenital heart disease: ventricular septal defect. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;499–505.
17. Patterson DF. Congenital defects of the cardiovascular system of dogs. Studies in comparative cardiology. Adv Vet Sci Comp Med 1976;20:1–37.
18. Tidholm A. Retrospective study of congenital heart defects in 151 dogs. J Small Anim Pract 1997;38:94–98.
19. Oliveira P, Domenech O, Silva J, et al. Retrospective review of congenital heart disease in 976 dogs. J Vet Intern Med 2011;25:477–483.
20. Liu SK. Pathology of feline heart disease. Vet Clin North Am 1977;7:323–339.
21. Riesen SC, Kovacevic A, Lombard CW, et al. Prevalence of heart disease in symptomatic cats: an overview from 1998 to 2005. Schweiz Arch Tierheilkd 2007;149:65–71.
22. Chetboul V, Charles V, Nicolle A, et al. Retrospective study of 156 atrial septal defects in dogs and cats (2001–2005). J Vet Med A Physiol Pathol Clin Med 2006;53:179–184.
23. Chetboul V, Concordet D, Pouchelon JL, et al. Effects of inter- and intra-observer variability on echocardiographic measurements in cats. J Vet Med A Physiol Pathol Clin Med 2003;50:326–331.
24. Chetboul V, Athanassiadis N, Concordet D, et al. Observer dependent variability of quantitative clinical endpoints: the example of canine echocardiography. J Vet Pharmacol Ther 2004;27:49–56.
25. Hansson K, Häggström J, Kvart C, et al. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavaliers King Charles Spaniel with and without left atrial enlargement. Vet Radiol Ultrasound 2002;43:568–575.
26. Boon JA. Congenital shunts and AV valve dysplasia. In: Boon JA, ed. Manual of veterinary echocardiography. 2nd ed. Baltimore: Wiley-Blackwell, 2011;437–475.
27. Hornberger LK, Sahn JS, Krabill KA, et al. Elucidation of the natural history of ventricular septal defects by serial Doppler color flow mapping studies. J Am Coll Cardiol 1989;13:1111–1118.
28. Moïse NS. Doppler echocardiography. J Vet Intern Med 1989;3:201–203.
29. Otto CM. Echocardiographic evaluation of the adult with unoperated congenital heart disease. In: The practice of clinical echocardiography. 2nd ed. Philadelphia: WB Saunders Co, 2002;884–887.
30. Boon JA. Acquired valvular disease. In: Boon JA, ed. Manual of veterinary echocardiography. 2nd ed: Baltimore: Wiley-Blackwell, 2011;267–335.
31. Serres F, Chetboul V, Tissier R, et al. Quantification of pulmonary to systemic flow ratio by a Doppler echocardiographic method in the normal dog: repeatability, reproducibility, and reference ranges. J Vet Cardiol 2009;11:23–29.
32. Bussadori C, Carminati M, Domenech O. Transcatheter closure of a perimembranous ventricular septal defect in a dog. J Vet Intern Med 2007;21:1396–1400.
33. Jacobs JP, Burke RP, Quintessenza JA, et al. Congenital heart surgery nomenclature and database project: ventricular septal defect. Ann Thorac Surg 2000;69(suppl 4):S25–S35.
34. Liu SP, Li L, Yao KC, et al. Investigation of membranous ventricular septal defect complicated with tricuspid regurgitation in ventricular septal defect occlusion. Exp Ther Med 2013;5:865–869.
35. Spicer DE, Anderson RH, Backer CL. Clarifying the surgical morphology of inlet ventricular septal defects. Ann Thorac Surg 2013;95:236–241.
36. Shimizu M, Tanaka R, Hoshi K, et al. Surgical correction of ventricular septal defect with aortic regurgitation in a dog. Aust Vet J 2006;84:117–121.
37. Soto B, Ceballos R, Kirklin JW. Ventricular septal defects: a surgical viewpoint. J Am Coll Cardiol 1989;14:1291–1297.
38. Le Boedec K, Arnaud C, Chetboul V, et al. Relationship between paradoxical breathing and pleural diseases in dyspneic dogs and cats: 389 cases (2001–2009). J Am Vet Med Assoc 2012;240:1095–1099.
39. Rausch WP, Keene BW. Spontaneous resolution of an isolated ventricular septal defect in a dog. J Am Vet Med Assoc 2003;223:219–220.
40. Shimizu M, Tanaka R, Hirao H, et al. Percutaneous transcatheter coil embolization of a ventricular septal defect in a dog. J Am Vet Med Assoc 2005;226:69–72.
41. Sisson DD, Luethy M, Thomas WP. Ventricular septal defect accompanied by aortic regurgitation in five dogs. J Am Anim Hosp Assoc 1991;27:441–447.
42. Peddle GD, Boger L, Van Winkle TJ, et al. Gerbode type defect and third degree atrioventricular block in association with bacterial endocarditis in a dog. J Vet Cardiol 2008;10:133–139.
43. Quintavalla C, Mavropoulou A, Buratti E. Aortic endocarditis associated with a perforated septal membranous aneurysm in a Boxer dog. J Small Anim Pract 2007;48:330–334.
44. Monnet E, Orton EC, Gaynor J, et al. Diagnosis and surgical repair of partial atrioventricular septal defects in two dogs. J Am Vet Med Assoc 1997;211:569–572.
45. Fujii Y, Fukuda T, Machida N, et al. Transcatheter closure of congenital ventricular septal defects in 3 dogs with a detachable coil. J Vet Intern Med 2004;18:911–914.
46. Margiocco ML, Bulmer BJ, Sisson DD. Percutaneous occlusion of a muscular ventricular septal defect with an Amplatzer Muscular VSD occluder. J Vet Cardiol 2008;10:61–66.
47. Thomas WP. Echocardiographic diagnosis of congenital membranous ventricular septal aneurysm in the dog and cat. J Am Anim Hosp Assoc 2005;41:215–220.
48. Tou SP, Keene BW, Barker PCA. Pulmonary atresia and ventricular septal defect with aortopulmonary collaterals in an adult dog. J Vet Cardiol 2011;13:271–275.
49. Piantedosi D, Cortese L, Meomartino L, et al. Situs invertus totalis associated with subaortic stenosis, restrictive ventricular septal defect, and tricuspid dysplasia in an adult dog. Can Vet J 2011;52:1237–1242.
50. Brown WA. Ventricular septal defects in the English Springer Spaniel. In: Bonagura JD, Abbott JA, Abrams KL, eds. Kirk’s current veterinary therapy XII: small animal practice. Philadelphia: WB Saunders Co, 1995;827–830.
51. Matic SE. Congenital heart disease in the dog. J Small Anim Pract 1988;29:743–759.
52. Patterson DF, Pexieder T, Schnarr WR, et al. A single major-gene defect underlying cardiac conotruncal malformations interferes with myocardial growth during embryonic development: studies in the CTD line of Keeshond dogs. Am J Hum Genet 1993;52:388–397.
53. Guihaire J, Haddad F, Mercier O, et al. The right heart in congenital heart disease, mechanisms and recent advances. J Clin Exp Cardiolog 2012;8:1–11.
54. Kazmi U, Sadiq M, Hyder SN. Pattern of ventricular septal defect and associated complications. J Coll Physicians Surg Pak 2009;19:342–345.
55. Chaudhry TA, Younas M, Baig A. Ventricular septal defect and associated complications. J Pak Med Assoc 2011;61:1001–1004.
56. Tweddell JS, Pelech AN, Frommelt PC. Ventricular septal defect and aortic valve regurgitation: pathophysiology and indications for surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006;9:147–152.
57. Kardon RE, Cao QL, Masani N, et al. New insights and observations in three-dimensional echocardiographic visualization of ventricular septal defects: experimental and clinical studies. Circulation 1998;98:1307–1314.
58. Bonagura JD, Lehmkuhl LB. Congenital heart disease. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;471–535.
59. Eyster GE. Atrial septal defect and ventricular septal defect. Semin Vet Med Surg (Small Anim) 1994;9:227–233.
60. Keane JF, Plauth WH, Nadas AS. Ventricular septal defect with aortic regurgitation. Circulation 1977;56(suppl 1):I72–I77. Lun K, Li H, Leung MP, et al. Analysis of indications for surgical closure of subarterial ventricular septal defect without associated aortic cusp prolapse and aortic regurgitation. Am J Cardiol 2001;87:1266–1270.
62. Corone P, Doyon F, Gaudeau S, et al. Natural history of ventricular septal defect. A study involving 790 cases. Circulation 1977;55:908–915.
63. Gersony WM, Hayes CJ, Driscoll DJ. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993;87:121–126.
CHV des Cordeliers
Adresse de la clinique
Nous utilisons des cookies sur notre site web pour faciliter votre utilisation. Pour en savoir plus.
Notre site web utilise des cookies pour vous distinguer des autres utilisateurs de notre site web. Cela nous aide à vous offrir une bonne expérience lorsque vous naviguez sur notre site web et nous permet également d'améliorer notre site web. Voir notre politique en matière de cookies.
Nous utilisons 3 types de cookies différents sur notre site web. Vous pouvez indiquer ci-dessous ceux que vous souhaitez que nous utilisions.
Ces cookies servent à assurer la sécurité du site web. Ils doivent toujours être activés.